Literature DB >> 11386793

Epilepsy, depression and antidepressant drugs.

M R Salzberg1, F J Vajda.   

Abstract

Apart from constituting an important management problem, depression coexisting with epilepsy is also an interesting psychiatric phenomenon, with multiple interacting biological, psychological and social factors involved in its causation. New research approaches to the study of epilepsy and depression, including neuroimaging, neurochemical and neuroendocrine techniques, and the arrival of new classes of antidepressants in recent years, suggest it is timely to reconsider this topic. We review current knowledge of the prevalence and causes of interictal depression in epilepsy, focussing mainly on neurobiological factors, and give an overview of recent concepts concerning the management of depression. We also discuss pharmacological treatment of depression in epilepsy, focussing on the association between antidepressants and seizures, and drug interactions. Copyright 2001 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11386793     DOI: 10.1054/jocn.2000.0896

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  6 in total

Review 1.  Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?

Authors:  L Cardamone; M R Salzberg; T J O'Brien; N C Jones
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

2.  Inhibition of the human two-pore domain potassium channel, TREK-1, by fluoxetine and its metabolite norfluoxetine.

Authors:  Louise E Kennard; Justin R Chumbley; Kishani M Ranatunga; Stephanie J Armstrong; Emma L Veale; Alistair Mathie
Journal:  Br J Pharmacol       Date:  2005-03       Impact factor: 8.739

3.  Enhancement of dorsal hippocampal activity by knockdown of HCN1 channels leads to anxiolytic- and antidepressant-like behaviors.

Authors:  Chung Sub Kim; Payne Y Chang; Daniel Johnston
Journal:  Neuron       Date:  2012-08-09       Impact factor: 17.173

4.  Effect of acute and chronic treatment with milnacipran potentiates the anticonvulsant activity of conventional antiepileptic drugs in the maximal electroshock-induced seizures in mice.

Authors:  Kinga K Borowicz; Kamila Furmanek-Karwowska; Marta Morawska; Jarogniew J Luszczki; Stanislaw J Czuczwar
Journal:  Psychopharmacology (Berl)       Date:  2009-10-20       Impact factor: 4.530

5.  Acute and chronic treatment with mianserin differentially affects the anticonvulsant activity of conventional antiepileptic drugs in the mouse maximal electroshock model.

Authors:  Kinga K Borowicz; Monika Banach; Radosław Zarczuk; Dariusz Lukasik; Jarogniew J Luszczki; Stanislaw J Czuczwar
Journal:  Psychopharmacology (Berl)       Date:  2007-07-26       Impact factor: 4.530

6.  Depression in temporal lobe epilepsy: a review of prevalence, clinical features, and management considerations.

Authors:  C S Garcia
Journal:  Epilepsy Res Treat       Date:  2011-12-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.